Introduction
The cytochromes P450 (CYP) play major roles in the metabolism of a wide variety of small molecules including drugs, steroids and carcinogens. CYP-dependent catalysis dominates drug metabolism accounting for an approximate 75% of biotransformation of clinically relevant drugs (Guengerich, 2008) . Metabolism of a substrate by CYP enzymes generally results in the formation of a more hydrophilic and readily excretable product. As such, CYP activity is a critical contributor to the clearance of many drugs. CYP enzymes are divided into families and subfamilies based on amino acid sequence identity. CYPs belonging to the 1A, 2A, 2B, 2C, 2D
and 3A subfamilies have been demonstrated to primarily participate in drug metabolism (Guengerich and Cheng, 2011) . The CYP family contains 57 human and 102 murine putatively functional genes (Nelson et al., 2004) . Although mice are widely used in preclinical pharmacological studies, current understanding of the expression patterns of murine CYP family members at the protein level is limited largely due to the lack of availability of antibodies that react with specific mouse CYP enzymes. As a result, much of what is known regarding the expression of murine CYPs has relied solely on the analysis of mRNA levels.
The application of mass spectrometry-based global proteomics facilitates the highthroughput analysis of complex protein samples; however, a limitation of this technique is that the stochastic nature of its scan-dependent acquisition can result in bias towards the detection of higher abundance proteins. As a result, lower abundance proteins can be difficult to quantitate when global profiling is performed. The use of targeted proteomics can overcome this limitation since data acquisition is aimed at the detection of specific proteins of interest. One such targeted method is selected reaction monitoring (SRM), which is generally performed using a triple-quadrupole mass spectrometer. In this approach, sensitivity and selectivity are increased through the monitoring of a particular fragment ion of a selected precursor ion (Lange et al., 2008) . The specific pair of mass-to-charge ratios associated with the precursor ion and This article has not been copyedited and formatted. The final version may differ from this version.
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5 the fragment ion is referred to as a "transition". The use of these transitions allows for a selected number of peptides to be monitored instead of all peptides present in the mixture being measured simultaneously as is the case in global proteomics. This feature of SRM targeted proteomics allows for the reproducible detection and quantification of both low-and highabundance proteins in complex mixtures over a wide dynamic range (Picotti et al., 2009 ).
In the present study, we describe a targeted SRM-based proteomics approach that can be used to simultaneously quantitate 27 murine CYP enzymes including those belonging to subfamilies involved in drug metabolism. In developing the assay, we first applied global proteomics to mouse tissue in order to compile a list of CYP protein that were detectable via mass spectrometry. We then identified transitions unique to each CYP that would facilitate detection of these enzymes in a multiplexed fashion in a complex protein mixture. Through the incorporation of heavy-isotope labeled peptides, quantitation of the targeted CYP proteins was achieved over several orders of magnitude. In order to demonstrate the utility of the assay, we characterized CYP enzyme expression in the liver, kidney, lung, intestine, heart and brain of male and female Balb/c mice at 3-4 weeks, 9-10 weeks and 8-10 months of age. In addition, CYP protein levels were measured in each of these organs in pregnant mice while fetal CYP enzyme abundance was analyzed in liver and brain. This assay can be employed broadly and leveraged in order to gain insight into expression patterns of murine CYPs including in response to drug treatments, physiological states and genetic modification. 
Methods

Chemicals and Reagents
Efavirenz ((4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one) was purchased from Toronto Research Chemicals (Toronto, ON, Canada).
NADPH was purchased from BD Biosciences (San Jose, CA). Iodoacetamide, phenylmethanesulfonyl fluoride, and urea were obtained from Sigma Aldrich (St. Louis, MO).
Hexanes and ethyl acetate were purchased from Thermo Fisher Scientific (Sunnyvale, CA). All other chemicals were of the highest grade commercially available.
Mouse Tissue Preparation
Liver microsomes were prepared from the livers of male and female mice 3-4 weeks, 9-10 weeks, and 8-10 months of age in addition to pregnant mice (10-12 weeks of age) and fetuses (gestation day 16) as previously described (Raucy and Lasker, 1991) . Mice were euthanized as approved by the Johns Hopkins University Animal Care and Use Committee. Tissue total protein lysates were prepared from kidney, lung, intestine, heart and brain of the 10-12 weeks of age pregnant, 3-4 weeks, 9-10 weeks, and 8-10 months of age male and female mice. Brain was the only organ besides liver that was collected from fetuses. All fetal brains from an individual pregnant mother were pooled and lysed. Tissue was homogenized in lysis buffer containing 20 mM Tris HCl pH 7.5, 150 mM NaCl, 1mM ethylenediaminetetraacetic acid, 1 mM ethylene glycerol tetraacetic acid, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM betaglycerophosphate, 1mM Na 3 VO 4 , 1 μ g/ml leupeptin, and 1mM phenylmethylsulfonylfluoride (cell signaling, Danvers, MA). Samples were centrifuged at 10,000 x g for 30 minutes at 4°C, and the supernatants were saved. The microsomes and lysates that were isolated from 4 individual mice within the same age, organ, and sex group were pooled. Fetal liver microsomes and brain lysates from all pregnant mice were pooled. Protein concentration was determined using the trypsin: protein ratio for 18 hours at 37°C. The resulting peptide solution was removed and the remaining peptides were extracted from the gel using 0.1% trifluoroacetic acid, 50 mM Ambic, and 50% acetonitrile by incubation at 37°C for 1 hour. All of the peptides of each sample were combined before drying under vacuum. Samples were reconstituted in 10μl of mobile phase A, 2 μ l of which were injected for liquid chromatography-mass spectrometry (LC-MS) analysis.
Global Proteomics LC-MS Assay
Protein discovery experiments were performed by The Mass Spectrometry and Proteomics Facility at Johns Hopkins School of Medicine. Total protein lysates (heart, kidney, brain, lung and intestine) and liver microsomes isolated from a 9-10 week old male and a 9-10 week old 
In-solution Peptide Isolation for Targeted Proteomics
A proteomic SRM assay was developed to quantify the CYP proteins identified in the datadependent mass spectrometry experiment. Samples for the targeted assay were prepared using the filter-aided sample preparation method developed by Matthias Mann (Wisniewski et al., 2009 ). The targeted assay was applied to the previously described microsomes, including male and female Balb/c mice of 3 ages plus pregnant mice and fetuses. In addition, pooled tissue lysates (n=4) from these mice were analyzed, including kidney, lung, intestine, heart and brain. Tissue lysates or microsomes (100 
Targeted Proteomics LC-MS Assay
To write the mass spectrometric method and view the targeted method data, the open source program Skyline (MacCoss Lab, University of Washington School of Medicine) was employed. sequence started at 5% B for 2 minutes, increased to 60% B to 26 minutes, 98% to 27 minutes, 5% to 28 minutes, and remained at 5% to 30 minutes. Mass-to-charge ratio of all quantitative and confirmatory peptides and transitions are indicated in Table 1 and Supplementary Table 1 .
Cycle time was 5 seconds, peak widths for Q1 and Q3 were 0.70 FWHM, and Chromatographic
Filter Peak Width was set to 50 seconds. All ions were monitored in positive mode and analyzed using Thermo Xcalibur software (version 2.1; Sunnyvale, CA).
Proteomics Quantification
The isotope labeled peptide standards were prepared in triplicate by spiking Balb/c mouse liver microsomes, following the sample preparation procedure described above, with dilutions of 
EFV Metabolite LC-MS Assay
The EFV metabolism assay was performed as previously described (Avery et al., 2013) Scan time was 0.1, peak widths for Q1 and Q3 were 0.70 FWHM, and collision energies were 14, 17, and 14, respectively. Signal intensities of EFV metabolites were normalized using the intensity of the fluorinated EFV peak intensity. Product ions were scanned from m/z 50 to 370.
All ions were monitored in negative ionization mode. 
Statistical Analysis
Graphs and one-way ANOVA F-statistics with Bonferroni corrections were performed using GraphPad Prism version 6.02 for Windows (GraphPad Software Inc., San Diego, CA).
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Results
A targeted proteomics method using mass spectrometry in selected reaction monitoring mode was developed in order to simultaneously measure protein levels of murine CYPs 1A2, 2A12, 2B9, 2B10, 2C29, 2C37, 2C39, 2C50, 2C54, 2C67, 2C70, 2D9, 2D10, 2D22, 2D26, 2E1, 2F2, 2J5, 2U1, 3A11, 3A13, 3A25, 4A10, 4A12A, 4B1, 4F13 and 4V2. These CYP enzymes were identified for incorporation into this multiplexed assay based on an initial global unbiased proteomics screen that detected each of these proteins in tissue lysates and liver microsomes isolated from 9-10 week male or female Balb/c mice. The multiplexed screen was refined using the mouse liver microsomes. The workflow for the development of the assay and subsequent sample analysis is depicted in Figure 1 . Liver was chosen for these initial studies since this organ is the predominant site of drug metabolism and as such contains an abundance of CYP enzymes. In addition, since CYPs are microsomal proteins we isolated microsomes from mouse livers in order to increase the ability to detect CYP enzymes and to also allow for parallel analysis of protein levels and metabolic activity towards a substrate. The peptides and SRM transitions optimized to detect each protein are listed in Table 1 (SRM transitions used for quantitation) and Supplemental Table 1 (all SRM transitions used for detection of each CYPspecific peptide). The limit of quantitation and linear range of each peptide quantitative assay is shown in Supplemental Table 2 . Differential expression of several CYP enzymes were observed in liver microsomes isolated from male and female Balb/c mice 3-4 week, 9-10 week, and 8-10 months of age ( Fig. 2A) . In addition, liver microsomes from 10-12 week old pregnant mice and mixed sex fetuses (gestation age 16) were screened ( Fig. 2A) . The most consistently abundant proteins across age in both males and non-pregnant females were CYPs 2C29, 2D26, 2D10 and 2E1. Expression of CYP1A2 appeared to be sexually dimorphic as it was more abundant in male mice as compared to females across all age groups investigated. CYP4A12A
protein levels were found to be lower in liver microsomes isolated from adult (9-10 week old and 8-10 month old) female mice as compared to age-matched males. CYP2E1 appeared to be less abundant in livers from pregnant mice than in all other groups while the levels of CYP2B9 detected were higher in pregnant mice than in non-pregnant adult females and adult males. Of note, the levels of hepatic CYP2B9 in 3-4 week males and females were greater than adult males and non-pregnant adult females. CYPs 4A10 and 4F13 were detected in high abundance in 3-4 weeks of age female mouse liver microsomes, while the levels of these enzymes were below the limit of quantitation at all other ages. Fetal liver expressed CYPs 2B9, 2C37, 2D9, 2D10, and 2D26.
Activity of the liver microsomes that were analyzed using proteomics was probed in parallel using the anti-HIV drug efavirenz (EFV) as a substrate. EFV was chosen for the activity assays since we and others have demonstrated that multiple human CYP subfamilies can contribute to the oxidative metabolism of this drug (Ward et al., 2003; Ogburn et al., 2010; Avery et al., 2013) . Metabolism of EFV in mice has yet to be previously reported. Mouse microsomal metabolism of EFV resulted in the formation of two monooxygenated metabolites (Fig. 3A) as measured using ultra high performance liquid chromatograph tandem mass spectrometry (uHPLC-MS/MS). The metabolite with retention time 3.89 min (Fig. 3A) was identified as 8-hydroxyEFV (8-OHEFV), which is the primary metabolite of EFV formed in humans, based on comparison of the retention time and fragmentation pattern of this analyte with a synthetic standard. The fragmentation spectrum of the metabolite with retention time 2.81 min (Supplemental Fig. 1 ) was largely identical to that of 8-OHEFV indicating that the oxygen insertion was occurring on the same ring that encompasses the 8-position, although the metabolite that eluted at 2.81 appeared to be more hydrophilic based on the retention time. A 7-hydroxyEFV metabolite has also been previously described; however, this synthetic standard eluted later than the 2.81 min metabolite. As such, we propose that this metabolite is 5-hydroxyEFV (5-OHEFV). No additional metabolites were detectable in these mouse liver microsome assays. Formation of 8-OHEFV (Fig. 3B ) and 5-OHEFV (Fig. 3C ) by liver microsomes isolated from livers of 3-4 week old females was lower than that of 9-10 week old female liver microsomes (p=0.0045 and p=0.0326, respectively). In addition, 8-OHEFV and 5-OHEFV were less abundant in the incubations containing the 3-4 week-old female liver microsomes as compared to males of the same age (p=0.0412 and p=0.0150, respectively). Interestingly, sex differences in EFV metabolite formation were not observed using liver microsomes isolated from the 9-10 week or 8-10 month old mice. Liver microsomes from pregnant mice (10-12 weeks of age) demonstrated significantly higher 8-OHEFV production in comparison to 9-10 week old females (p=0.0289), whereas 5-OHEFV was significantly lower (p=0.0355). Fetal liver microsomes did not demonstrate activity towards EFV.
To gain an understanding of murine CYP protein expression in extrahepatic tissues, kidney, lung, brain, intestine and heart total protein lysates from the Balb/c mice were analyzed using the targeted proteomics assay. Total protein lysates were analyzed for these tissues as opposed to microsomes since the protein yields for microsomal preparations from these organs were far below that of liver. Ten of the 27 CYP enzymes were detected in kidney lysates (Fig.   2B ). CYPs 4A12A, 2B9, and 4A10 exhibited the highest levels. Kidney was the only extrahepatic organ that expressed detectable levels of CYP2E1 and this expression was malespecific. Conversely, CYP3A25 was only detected in adult non-pregnant female kidney lysates and CYP2D26 was predominantly expressed in female kidney lysates, including expression in kidney isolated from pregnant mice. Interestingly, the kidney exhibited the greatest sex-specific trends in CYP protein levels. The number of CYP enzymes identified in lung tissue was second only to liver expression: 15 of the 27 proteins screened were detected in lung tissue (Fig. 2C ).
CYPs 4A12A, 2F2 and 2B9 were amongst the most highly expressed CYP proteins in lung protein lysates. In contrast to the kidney, no sex-, age-, or pregnancy-specific trends were identified in lung tissue. While CYPs 2C67 and 4V2 were expressed in lung they were not detectable in other extrahepatic tissues. Besides liver, only brain could be isolated from fetuses in sufficient quantities. CYP2B9 was the sole CYP enzyme that was detectable in all of the Balb/c brain lysates analyzed (Fig. 2D) . Similar to what was observed for liver microsomes, CYP2B9 was found in higher abundance in the male and female mice that were 3-4 weeks of age than in older mice. In addition to Cyp2B9, fetal brain lysate expressed CYPs 3A25, and 4A12A while CYP2C29 was detected in the brain lysates of 8-10 months old female Balb/c mice. Proteins detected in the greatest number of intestine lysates analyzed in these studies were CYPs 2C29, 4A12A, and 3A25 (Fig. 2E) . CYPs 3A13, 2J5, 2C37, 4B1 and 4A10 were also detected. CYP4B1 was found at higher levels in pregnant mice than in age-matched nonpregnant female intestine lysates. CYPs 2C70 and 2J5 were the most frequently detected CYP enzymes in heart lysates ( Fig. 2F ). CYPs 4A12A, 2F2, 3A25, and 4B1 were also detected. No sex-, age-, or pregnancy specific trends were identified through the analysis of the heart lysates.
Discussion
Here we describe the development of a targeted proteomics assay, a powerful tool that can be broadly applied in order to probe the impact of small molecules and pathophysiological states on the expression of murine CYP enzymes. In order to demonstrate the application of this assay, we present an analysis of CYP protein expression patterns in male and female mice over a range of ages in several organs. Previous reports have relied overwhelmingly on mRNA analyses; therefore, our studies provide novel insight into murine CYP distribution at the protein level. Genomic analyses have identified 102 murine CYP genes; however, it is not currently known how many CYP proteins are expressed in mice. In the current study, we found 27 murine CYP enzymes were readily detectable and distinguishable using mass spectrometry. CYPs 4B1, 3A25, 4A12A, and 2C29 were the most consistently expressed amongst the mouse organs analyzed although a number of age-, sex-and pregnancy-dependent trends were noted in the expression of these and other CYPs.
Amongst the consistently expressed CYPs, CYP4B1 expression was elevated in adult male kidney as compared to age matched females and this is consistent with previous reports of dimorphic expression of CYP4B1 mRNA (Renaud et al., 2011) . Further, CYP3A25 mRNA has been shown to be expressed most prominently in liver and intestines and this finding is in line with our proteomics results (Renaud et al., 2011) . Similar to the results presented here, CYP2C29 mRNA has been shown to be mainly expressed in liver and lung, but also in many other organs (Choudhary et al., 2003) . CYP2C29 detoxifies alpha-and beta-unsaturated aldehydes, found endogenously, in food, and in the environment, which can otherwise react with genomic material (Amunom et al., 2011) . Our data identified CYP2B9 as the most abundant murine CYP in brain and sexually dimorphic expression was not observed. In addition, CYP2B9
protein was identified here in both fetal liver and brain.
Striking differences in CYP expression were noted between organs. The kidney CYPs 2D26, 2B9, and 2E1. This trend was most striking for CYP2E1 which appeared to be expressed only in the kidneys of male mice. Interestingly, this pattern of expression was not observed in liver. Levels of CYP2E1 in pregnant liver were markedly lower than in age matched female Balb/c mice. CYP protein expression in lung parallels previously observed expression patterns for human enzymes. In particular, Bieche et al. determined that human CYP2F1 was predominantly expressed in lung as compared to other extrahepatic tissues (Bieche et al., 2007) . In our study, we found that murine CYP2F2 was one of the more abundant CYP enzymes in lung. Drug metabolizing enzymes in lung are particularly important for environmental toxins and drugs delivered by inhalation. Since the intestine can contribute to first-pass metabolism following oral administration of a drug, understanding the expression of CYP enzymes in this organ is of interest. In the present study, enzymes belonging to the CYP3A and CYP2C subfamilies were identified in intestine and this is consistent with previous human studies (Ding and Kaminsky, 2003) . The CYP4A, CYP4B, and CYP2J subfamilies were also identified in mouse intestine and interestingly, these enzymes have not be previously shown to be expressed in either human or mouse intestine (Zhang et al., 2003) . CYP2J5 was readily detectable in all mouse liver microsomes except for those isolated from pregnant mice.
In addition, this enzyme was undetectable in the heart of 8-10 month female mice as well as pregnant mice. Localization of human CYP2J2 in heart is well characterized (Bieche et al., 2007) as is its role in xenobiotic metabolism and the pathogenesis of heart disease (Xu et al., 2013) ; however, our results raise the intriguing possibility that CYP2J protein may be differentially expressed during pregnancy. The assay developed here can facilitate investigations into the impact of pregnancy on the regulation of CYP2J protein. Human subfamily CYP2C is known to contribute to ischemic heart disease, and while CYP2C mRNA is not particularly abundant in murine heart (Renaud et al., 2011) , the proteomic results presented in our work suggest expression of a murine CYP2C, namely CYP2C70, at all ages in heart.
Knowledge of fetal CYP expression can lend insight to our understanding of the capacity of neonates to metabolize and clear xenobiotics. While CYP2B9 was detectable in the brains of all mice, CYPs 3A25 and 4A12A were detected only in fetal brain indicating that neural expression of these enzymes decreases after birth.
The limitations of this study include the use of whole organ homogenates (for brain, kidney, lung, heart, and intestine), the small sample size (use of only 4 animals), the use of pooled samples and the examination of only a small sampling of ages including one gestation stage. The small number of animals used in addition to the pooling of samples does not allow for the analysis of inter-individual differences in the expression of CYP enzymes in mice;
however, the use of pooled samples in the present study enabled the broad proof-of-concept application of the assay described here for use in screening murine CYP expression in multiple tissues and age groups. Subsequent studies using a larger sample number are required in order to gain a more detailed understanding of quantitative differences in expression amongst these groups. In addition, because organs were homogenized, the expression levels of CYP enzymes that we estimated do not reflect cell-type specific levels of CYP expression within the tissues analyzed; however, the method that we developed could be applied to protein lysates isolated from specific cell-types of interest. Finally, in order to gain a comprehensive understanding of CYP expression during pregnancy, fetal development and development after birth mice would need to be examined at ages and gestational stages beyond those in this study.
Mouse CYP activity towards the anti-HIV drug EFV revealed significant differences between mice of varying age, sex, and pregnancy status. Microsomes prepared from pregnant mouse livers formed more 8-OHEFV than those isolated from age matched female mice. While humans and mice may metabolize drugs differently, it is interesting to note that pregnant women taking EFV demonstrate increased metabolism of EFV in comparison to after birth (Cressey et al., 2012) . In addition, since formation of 8-OHEFV and 5-OHEFV using liver microsomes isolated from pregnant mice were significantly increased and decreased, respectively, more than one murine CYP enzyme may contribute to the metabolism of EFV. Further, we detected a metabolite that we propose to be 5-OHEFV. This identification was based on the fragmentation pattern of this analyte and the difference in retention time as compared to authentic standards for EFV metabolites oxygenated at the 7-or 8-positions. This product has not been noted in previous reports of EFV metabolism, however, none of these studies have examined metabolism of EFV in mice.
In humans, multiple enzymes contribute to the metabolism of EFV, but human CYP2B6 is known to contribute the most to the formation of the primary metabolite, 8-OHEFV. While we are not able to conclude which murine CYP enzyme(s) catalyzed the metabolism of EFV in our mouse liver microsome experiments, murine CYP2B9 and CYP2B10 are homologous to human CYP2B6. It is interesting to note that while our proteomics studies demonstrated that CYP2B9
was expressed in fetal liver microsomes, EFV was not metabolized by these microsomes.
Further, our proteomic profiles did not reveal age-, sex-or pregnancy related patterns of CYP2B10 expression that alone would be commensurate with the differential metabolism of EFV across these groups. Taken together, these data indicate that enzymes beyond CYP2B9
and CYP2B10 may contribute to EFV metabolism in mice. In addition, through these data we were able to demonstrate that the microsomes analyzed in the proteomics studies exhibited metabolic activity and also showed age-, sex-, and pregnancy-dependent differences in activity.
In summary, we have developed a targeted proteomics assay that can be utilized to simultaneously measure the expression of 27 murine CYPs belonging to subfamilies that play key roles in drug metabolism. Through the application of this assay, we have performed a comprehensive analysis of the expression of these CYPs across age, sex and pregnancy status. This assay broadly enables investigation of the impact of xenobiotics, pathophysiological stimuli and genetic modification on CYP protein expression in mice.
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